CS Paper Radar

ILR-SMO: Iterative Latent Refinement for Robust Spatial Multi-Omics Integration

Anqi Yu, Xudong Xu, Jianzhi Lu, Yuqi Sun, Bingguo Chen, Chenxi Ma, Weimin Tan, Bo Yan

cs.LG ·submitted 2026-11-02 11:00 UTC · v1
top venue

Abstract

Spatial multi-omics technologies jointly profile diverse molecular modalities with spatial context, providing a comprehensive view of cellular heterogeneity and tissue organization. To integrate spatial multi-omics data and identify spatial domains, a wide range of unsupervised methods has been proposed. However, recent approaches rely on single-step fusion, directly aggregating heterogeneous modalities into a shared representation, making embeddings sensitive to modality imbalance and measurement noise that are inherent to spatial multi-omics data, as well as unstable optimization under weak supervision. Here, we propose ILR-SMO (Iterative Latent Refinement for Spatial Multi-Omics), a unified self-supervised framework that reformulates multimodal integration as a stability-aware refinement process over a shared latent representation. Instead of single-step plain fusion, ILR-SMO progressively integrates modality-specific information through sequential updates, allowing information to be injected in a controlled manner. This incremental refinement enables later updates to correct or compensate for earlier deviations, resulting in more stable and robust representation learning under heterogeneous and noisy modalities. ILR-SMO further incorporates reliability-aware modality gating for adaptive modulation of modality contributions, and employs a joint objective to enforce spatial coherence while preventing representation collapse. Extensive experiments on five spatial multi-omics benchmarks demonstrate that ILR-SMO consistently outperforms seven state-of-the-art methods and exhibits strong robustness across diverse settings.

Comment
Author-corrected version of the IJCAI-ECAI 2026 paper. Four numerical typographical errors in Table 1 have been corrected, and the caption has been clarified regarding V-measure and NMI. The method rankings and conclusions remain unchanged
Journal ref
Proceedings of the Thirty-Fifth International Joint Conference on Artificial Intelligence (IJCAI-26), pp. 5227-5235, 2026
DOI
10.24963/ijcai.2026/582

Closest papers

Nearest neighbours by meaning across the whole index.

SpaFactor: Lightweight Spatial Context-Aware Gene Program Modeling for Histology-to-Transcriptomics Inference

cs.LG q-bio.QM ·2026-09-23 ·Shiting Ruan, Xitong Ling, Qiming He, Ziyou Yan, Huaitian Yuan +4 more
similarity 0.71
Abstract

Spatial transcriptomics (ST) profiles gene expression within tissue architecture, but its cost and experimental complexity limit routine use. Predicting spatial expression from routinely available hematoxylin and eosin (HE) images therefore offers a scalable alternative. However, conventional methods often fit high-dimensional gene outputs as independent targets, overlooking the biological coordination among genes while remaining vulnerable to high-dimensional noise and overfitting. Existing attempts to address this limitation often rely on computationally heavy graph networks or complex auxiliary supervision. We therefore introduce SpaFactor, a lightweight and efficient low-rank morphology-program-gene factorization framework. At the input, SpaFactor efficiently fuses the visual representation of the central spot with multiscale local and regional neighborhood context, yielding a histologic representation that captures cellular morphology and microenvironmental heterogeneity. For modeling, a residual MLP stably learns a nonlinear mapping from the tissue microenvironment to low-dimensional latent gene programs. These activities are decoded through shared gene loadings into coordinated multi-gene expression predictions. Across five public cohorts, SpaFactor achieves the best aggregate performance, with particularly clear improvements for spatially variable genes, and more faithfully recovers biologically organized spatial patterns. These results demonstrate that lightweight joint modeling of tissue context and gene programs can improve both predictive accuracy and biological fidelity.

0.16

PaSTel: Anchoring Histology in Spatial Transcriptomics via Multi-Scale Hierarchical Bio-Prior Contrastive Pretraining

cs.CV cs.AI ·2026-08-14 ·Azim Dehghani Amirabad, Junchao Zhu, Pushpak Pati, Walid Abdelmoula, Tommaso Mansi +1 more
published similarity 0.69
Abstract · This paper was accepted to the 3rd ICML 2026 Workshop on Multi-modal Foundation Models and Large Language Models for Life Sciences

Spatial transcriptomics (ST) links tissue morphology with molecular programs, motivating multimodal pretraining methods that align histology images with gene expression. However, existing approaches suffer from two key limitations: spatially informative gene selection is often dominated by ubiquitous housekeeping genes, leading to weakly discriminative representations, and independent spot-patch alignment fails to capture spatial dependencies that are critical for tissue organization. To address these challenges, we introduce PaSTel, a hierarchical multimodal pretraining framework that integrates biological priors at three levels. At the spot level, TF-IDF reweighting is used to identify spatially informative genes; at the functional level, curated KEGG pathways serve as anchors for encoding global biological semantics; and at the regional level, spatial clustering aggregates neighboring spots to model meso-scale tissue structure. Across multiple downstream tasks, PaSTel consistently outperforms existing vision and vision-omics encoders, demonstrating that incorporating multiscale biological priors yields more informative and transferable representations for spatial transcriptomics.

0.50

Biology-Guided Context-Aware Residual Propagation for Spatial Gene Expression Prediction from Histology

cs.LG ·2026-10-26 ·Vu Van An, Long D. Nguyen, Ho Viet Duc Luong, Binh P. Nguyen
published similarity 0.69
Abstract · Accepted at The IEEE/CVF Winter Conference on Applications of Computer Vision 2027

Spatial transcriptomics provides spatially resolved molecular profiling, but its cost, limited throughput and experimental complexity hinder routine large-scale use. Predicting spatial gene expression from hematoxylin-and-eosin-stained histology images offers a scalable alternative, yet remains challenging because histology provides only an indirect morphological view of molecular activity. Existing methods typically decode expression from visual features in a single stage, even when enhanced with spatial aggregation, retrieval or multi-resolution fusion. This formulation is restrictive because spot-level expression reflects not only local morphology but also cellular identity, neighborhood composition and tissue-level organization. We propose BCARP, a Biology-guided Context-Aware Residual Propagation framework for histology-guided spatial transcriptomics prediction. Instead of directly predicting gene expression from histology embeddings, BCARP treats them as morphology visual priors and progressively refines spot representations in a transcriptomics-oriented latent space. Each refinement step integrates nuclei-guided local cellular context with prototype-guided global context propagation, enabling information exchange across both neighboring and spatially distant spots. A pattern-scale decoder further separates spatial expression into pattern prediction from raw expression with scale calibration. Evaluated on three ST datasets and ten HEST-1k cohorts, BCARP achieves the highest mean correlation-based performance against other baselines. Numerical results support biology-guided local-global residual propagation as an effective alternative to visual decoding for histology-to-transcriptomics prediction.

0.30

OmicSync: Reliability-Aware Spatial Multi-Omics Clustering with Evidence-Constrained LLM Reasoning

cs.CV ·2026-08-24 ·Rabeya Tus Sadia, Qiang Ye, Qiang Cheng
similarity 0.68
Abstract

Spatial multi-omics technologies jointly profile gene expression, surface proteins, and histology at each tissue spot, yet most spatial domain discovery methods provide only cluster assignments, without indicating assignment reliability, modality contributions, or why a domain decision should be trusted. We present OmicSync, a reliability-aware spatial multi-omics framework that couples unsupervised domain clustering with evidence-constrained LLM reasoning using model-derived per-spot signals, including assignment confidence, epistemic routing uncertainty, and modality-routing weights. These signals are converted into structured evidence dictionaries and used to generate standard, stepwise, counterfactual, contrastive, and uncertainty-focused explanations. OmicSync integrates a KAN-GCN backbone with spatial encoding, cross-modal fusion, uncertainty-aware routing, cell-type supervision, and missing-modality imputation. We further introduce OmicSync-R, which closes the reasoning-clustering loop by using automatically computed reasoning-quality scores as REINFORCE rewards, allowing reasoning coherence to shape the latent structure without backpropagating through the language model. Across four 10x CytAssist FFPE spatial proteomics benchmarks, OmicSync achieves the best average rank on Human Tonsil (1.44), Glioblastoma (1.78), and Tonsil Add-on (1.22), and second-best on Human Breast Cancer (2.33). OmicSync-R further improves ARI on Human Breast Cancer from 45.73 to 46.72 and outperforms existing methods on six of nine clustering metrics. Together, OmicSync and OmicSync-R enable reliability-aware, spot-level auditable spatial domain discovery guided by evidence-constrained reasoning.

0.26

ARO: Aligned Representation learning for multi-Omics data

cs.LG cs.AI ·2026-10-05 ·Amogh Singh, Yash Shah, Chiara D'Ercoli, Arash Mehrjou, Patrick Schwab +2 more
published similarity 0.68
Abstract · Proceedings of the ICML 2026 3rd Workshop on Multi-modal Foundation Models and Large Language Models for Life Sciences, Seoul, Korea

The high cost of functional molecular assays, and prevalence of missing modalities and unmatched samples in computational biology, create significant barriers to comprehensive multi-omic profiling, essential for capturing and reasoning over molecules, cells, tissues, and organisms. This work proposes a model that learns meaningful representations from multi-omics cancer data supporting the reconstruction of missing and unpaired modalities. Contrary to increasingly complex, larger models, e.g. Foundation Models (FMs), ARO prioritizes practical applicability in limited or incomplete data settings. ARO optimally reconstructs missing modalities (MSE of $0.15$ on the validation and test data in the Unmasked settings), with its learned latent embeddings enabling a downstream cancer classification task. Our findings indicate that analyzing diverse molecular layers as a single integrated system offers a reliable and cost-efficient approach, reducing dependence on large-scale experimental testing, while still supporting multi-omic exploration in limited data settings.

0.34

Path2ST: Hierarchical Cell-Tissue Grounded Cross-Modal Translation for Spatial Transcriptomics

cs.CV cs.AIcs.CL ·2026-08-11 ·Ruochen Liu, Wei Lou
top venuecode/data similarity 0.67
Abstract

Predicting spatial gene expression from hematoxylin and eosin (H\&E)-stained images offers a cost-effective alternative to spatial transcriptomics (ST). However, existing methods treat H\&E images as generic visual inputs and ignore their intrinsic biological hierarchy, where spatially organized cell types collectively form functional tissue microenvironments that govern local gene expression programs. To bridge this gap, we formulate H\&E-to-ST prediction as a cross-modal semantic translation task and propose Path2ST, a hierarchically grounded autoregressive framework featuring three key components: (i) a Hierarchical Cell-Tissue Conditioning mechanism that fuses explicit and implicit cellular features with tissue-level semantic representations to construct hierarchical conditioning signals; (ii) a Scale-Adaptive Autoregressive Generation process over a hierarchical semantic vocabulary, enabling coarse-to-fine, biologically consistent expression synthesis; and (iii) SpectraLoss, a full-spectrum objective that jointly enforces ordinal fidelity, models transcriptional bursts, and aligns semantic structures with cell types. Extensive experiments on three datasets demonstrate state-of-the-art performance, validating that Path2ST generates highly accurate and spatially coherent transcriptomic profiles. The related code is released at https://github.com/RuochenLiu23/Path2ST.

0.54

Predicting Single-Cell Spatial Gene Expression from H&E using Pathology Foundation Models

cs.CV ·2026-11-10 ·Ashley P. Tsang, Evan Liu, Conrad Foo, Bob Chen, Hassaan Maan +8 more
publishedcode/data similarity 0.66
Abstract · NeurIPS 2026 Workshop on AI at Scale for Clinical Impact. Project page: https://he2sc-st.github.io/

Predicting gene expression directly from hematoxylin and eosin (H&E) images offers a scalable and cost-effective approach to deriving spatial molecular insights from routine histology. Pathology foundation models, typically pretrained using tile-level objectives, may not adequately capture the fine-grained cellular features required for single-cell molecular prediction. In this work, we systematically evaluate and establish domain-informed and task-specific strategies for adapting pathology foundation models to single-cell spatial gene expression prediction. Using paired H&E and Xenium 5K data, our approach improves mean gene-wise Pearson correlation by 2.67x over the standard zero-shot baseline and achieves state-of-the-art performance on this task. We demonstrate strong gene-detection performance across the full gene panel (AUROC = 0.800) and importantly identify that predictive performance varies substantially across biological contexts, with our model achieving its highest Pearson correlation for spatially variable genes (r = 0.643). Our findings demonstrate that, despite the challenges of sparse single-cell measurements, H&E-derived representations can recover biologically meaningful spatial expression patterns, highlighting both the opportunities and limitations of morphology-based molecular inference at cellular resolution.

0.21

An Explainable and Scalable Hierarchical Tensor Framework for Integrating Multi-Omics and Digital Pathomics

cs.AI q-bio.GN ·2026-11-19 ·Ahmad Hussein, Ali Anaissi, Mukesh Prasad, Ali Braytee
similarity 0.66
Abstract

Background: Precision oncology requires integration of heterogeneous molecular and pathology data, yet many fusion models offer limited biologically grounded interpretability and struggle with missing modalities. Methods: We present Hierarchical Interpretable Tensor Fusion (HIT-Fuse), integrating six modalities: somatic copy number variation, DNA methylation, RNA sequencing, microRNA expression, RPPA protein abundance, and vision transformer-derived pathomics across four TCGA cohorts (glioma, lung adenocarcinoma, breast, and kidney cancer). Modality-specific autoencoders compress high-dimensional inputs, followed by two-stage CP tensor decomposition. Missing latent modalities are reconstructed using clinical covariates and observed omics to expand cohorts and retrain downstream models. A mathematical traceback mechanism enables global and local xAI attributions. Results: HIT-Fuse identifies distinct latent subgroups with significant survival stratification in glioma, breast, and kidney cohorts, both with complete and reconstructed modalities. Cohort expansion yields cohort-specific gains, including a 56.4% relative increase in weighted F1 for glioma. Biological validation against DepMap CRISPR screens, miRTarBase and RPPA annotations supports decoded drivers across all four cohorts. Essential gene rates range from 6.2% in glioma to 7.6% in lung cancer; example drivers include ANAPC11, SNRPD1, PLK1 and RPL14. Of decoded miRNAs, 71-92% have miRTarBase regulatory support, while 77-84% of selected genes are covered in DepMap. Conclusions: HIT-Fuse combines hierarchical tensor fusion, missing-modality reconstruction and traceable attributions to support interpretable multi-omics and digital pathology-based cancer prognosis across heterogeneous cohorts.

0.06